Early Access — free while we kick the tires
EdgarHawk

PARSHALL B LYNNE

Director

Director
1 filing analyzed · 1 company · Latest 2025-09-04

Companies

Company Buys Sells Direction
IONIS PHARMACEUTICALS INC IONS 0 2 Net selling

Activity

September 2025
medium
Sell
20,000 shares
$1,018,298
Significance 6/10

Director Parshall B Lynne sold 20,000 shares at blended avg $50.91, down 14.2% from current price $59.35.

Director Parshall B Lynne executed 2 separate sales totaling 20,000 shares for $1,018,297.50 on 2025-09-02, reducing her holdings by 23.2% to 66,344 shares. The transaction occurred at a blended average price of $50.91, notably 14.2% below the current price of $59.35, suggesting the sale was timed before the recent 37.9% 30-day and 68.2% 90-day rallies. Her prior 3 sales at IONS (all in late December 2023) showed a 100% well-timed rate at the 90-day mark, with negative subsequent returns across all three trades. This selling pattern in the context of the company's deteriorating fundamentals—revenue declining 10.5% annually and full-year net income negative—reflects a substantive reduction in her equity stake, though the recent price appreciation suggests she exited prior to market momentum rather than ahead of forward deterioration.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access